Verastem, Inc. (VSTM): New Bullish Coverage

VSTM – B. Riley FBR, Inc. initiates as a buy, $15PT. This price target represents a 341.18% upside over the stock’s previous closing price of $3.40.

Update: As of Jan. 18, 2019, this bullish analyst call has returned 1.76%.

Key Facts Surrounding This News Item

  • VSTM had a POWR Rating of D (Sell) coming into today.
  • VSTM was 6.15% above its 10-Day Moving Average coming into today.
  • VSTM was 5.19% above its 20-Day Moving Average coming into today.
  • VSTM was 5.65% above its 50-Day Moving Average coming into today.
  • VSTM was -1.34% below its 100-Day Moving Average coming into today.
  • VSTM was -2.08% below its 200-Day Moving Average coming into today.
  • VSTM had returned +10.75% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About Verastem, Inc. (VSTM)

Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts. View our full VSTM ticker page with ratings, news, and more.

VSTM at a Glance

VSTM Current POWR Rating™
Overall POWR Rating™
VSTM Current Price $3.46 2.37%
More VSTM Ratings, Data, and News

VSTM Price Reaction

The day of this event (Mar. 8, 2018)
VSTM Closing Price$3.53 3.82%
VSTM Volume1,198,300
32.77% from avg
Leading up to this event
VSTM 1-mo return2.72%
After this event
VSTM 1-day return1.45%
VSTM 3-day return1.19%
VSTM 5-day return3.66%

VSTM Price Chart

The Top Stocks For 2019

More Verastem, Inc. (VSTM) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All VSTM News
Page generated in 0.9651 seconds.